Study Details

Study ID 0819-CL-0201
Study Title A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients with Fibromyalgia Identifier NCT03056690
Compound Name ASP0819
Medical Indication or Disease Fibromyalgia
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 20-Mar-2017
Study Completion Date 27-Feb-2017
Clinical Study Result
Select the language
Plain Language Summary
Select the language